ConductScience.org, home

Paper2253000

Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.

Thompson RL and 3 others. Br J Surg, 1990. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Papers, record 2253000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2253000

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.
PubMed
Journal
Br J Surg
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
2.72
iCite
Revised in PubMed
2019-07-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thompson RLR L
2Hoper MM
3Diamond TT
4Rowlands BJB J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholestasisMajor topic
T-LymphocytesMajor topic
Animals
Biliary Tract
Bilirubin
Drainage
Female
Immunity, Cellular
Lymphocyte Activation
Rats
Rats, Inbred Strains
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in2059827Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.https://conductscience.org/library/papers/2059827

Source PubMed

Download CSV of comments and corrections

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
25326124Preoperative bile replacement improves immune function for jaundiced patients treated with external biliary drainage.J Gastrointest Surg2014https://conductscience.org/library/papers/25326124PubMed
21697460Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.J Immunol2011https://conductscience.org/library/papers/21697460PubMed
19533815Ampullary carcinoma: effect of preoperative biliary drainage on surgical outcome.World J Gastroenterol2009https://conductscience.org/library/papers/19533815PubMed
15024312The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora.Ann Surg2004https://conductscience.org/library/papers/15024312PubMed
14961202Changes in extrathymic T cells in the liver and intestinal intraepithelium in mice with obstructive jaundice.World J Surg2004https://conductscience.org/library/papers/14961202PubMed
11713939Immunologic influences of hyperthermia in a rat model of obstructive jaundice.Dig Dis Sci2001https://conductscience.org/library/papers/11713939PubMed
11575437External biliary drainage plus bile acid feeding is not equal to internal drainage in preserving the cellular immunity following prolonged obstructive jaundice.Dig Dis Sci2001https://conductscience.org/library/papers/11575437PubMed
10764720Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage.Gut2000https://conductscience.org/library/papers/10764720PubMed
8984035Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.Gut1996https://conductscience.org/library/papers/8984035PubMed
8943639Endotoxin, cellular immune dysfunction and acute pancreatitis.Ann R Coll Surg Engl1996https://conductscience.org/library/papers/8943639PubMed
8689926Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes.Dig Dis Sci1996https://conductscience.org/library/papers/8689926PubMed
8380975Improvements in survival by aggressive resections of hilar cholangiocarcinoma.Ann Surg1993https://conductscience.org/library/papers/8380975PubMed
8109118T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.World J Surg1993https://conductscience.org/library/papers/8109118PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2253000

GET https://conductscience.org/api/papers/v1/2253000/authors